Dicerna Pharmaceuticals
DRNA
#4023
Rank
S$3.78 B
Marketcap
S$48.62
Share price
0.00%
Change (1 day)
16,052.02%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: S$3.78 Billion

As of February 2026 Dicerna Pharmaceuticals has a market cap of S$3.78 Billion. This makes Dicerna Pharmaceuticals the world's 4023th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022S$3.99 B-0.84%
2021S$4.02 B82.33%
2020S$2.20 B3.86%
2019S$2.12 B113.39%
2018S$0.99 B59.72%
2017S$0.62 B621.03%
2016S$86.5 M-74.98%
2015S$0.34 B-10.67%
2014S$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$191.23 B 4,948.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$234.18 B 6,082.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$350.37 B 9,149.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S$0.71 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$56.81 B 1,399.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$12.34 B 225.99%๐Ÿ‡บ๐Ÿ‡ธ USA